Turnstone Biologics Corp.: Nasdaq/NYSE listing notice — Turnstone Biologics transfers to Nasdaq Capital Market; gets 180-day extension for bid price compliance

Turnstone Biologics Corp.

Turnstone Biologics received Nasdaq notice on Sep 27, 2024 for bid price below $1.00 for 30 consecutive days.
Transferred stock listing from Nasdaq Global Market to Capital Market, effective Mar 31, 2025, under same ticker TSBX.
Granted additional 180-day grace period until Sep 22, 2025 to regain compliance with minimum $1.00 bid price.
Company plans reverse stock split to meet bid price requirement, subject to stockholder vote via proxy.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Turnstone Biologics Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

rd; Transfer of Listing. As previously reported, on September 27, 2024, Turnstone Biologics Corp. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer met the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”) because the closing bid price for the Company’s common stock was less than $1.00 for the previous 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company had a 180-calendar day grace period, or until March 26, 2025, to regai

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-25-047944

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.